APA (7th ed.) Citation

T, M., K, S., T, N., K, S., N, O., & J, K. (2026). Relationships of serum levels of tocilizumab to interleukin-6 and endogenous markers of CYP3A activity in patients with rheumatoid arthritis. Annals of clinical biochemistry, 63(1), 49. https://doi.org/10.1177/00045632251357148

Chicago Style (17th ed.) Citation

T, Mochizuki, Shibata K, Naito T, Shimoyama K, Ogawa N, and Kawakami J. "Relationships of Serum Levels of Tocilizumab to Interleukin-6 and Endogenous Markers of CYP3A Activity in Patients with Rheumatoid Arthritis." Annals of Clinical Biochemistry 63, no. 1 (2026): 49. https://doi.org/10.1177/00045632251357148.

MLA (9th ed.) Citation

T, Mochizuki, et al. "Relationships of Serum Levels of Tocilizumab to Interleukin-6 and Endogenous Markers of CYP3A Activity in Patients with Rheumatoid Arthritis." Annals of Clinical Biochemistry, vol. 63, no. 1, 2026, p. 49, https://doi.org/10.1177/00045632251357148.